If you don't see your question here, our team is a message away.
FLA Peptides operates in partnership with a licensed medical practice. The two categories we support are sourced differently, and we're upfront about both: compounded medications (GLP-1s, HRT) are prepared by a licensed 503A pharmacy under an individual prescription following clinical evaluation. Research peptides (BPC-157, TB-500, and similar) are sourced as research-grade material from a specialty supplier — they are not compounded-pharmacy products, and whether one becomes part of your protocol is a clinical decision your provider makes based on your labs and history. Neither category is FDA-approved for the uses discussed here, and nothing moves forward without a provider reviewing your labs first.
No. Anyone can submit a request and go through the standard intake and lab review. If you were already on a protocol with us and have since moved, let us know in the notes field — we'll pick up where things left off without you starting over.
It depends on the protocol. Most require some combination of a Comprehensive Metabolic Panel (CMP), Complete Blood Count (CBC), lipid panel, or IGF-1. These give your provider a baseline picture of organ function, blood counts, and (for growth-hormone-related protocols) hormone response, so dosing decisions are based on your actual physiology rather than a guess.
We offer labs at cost through Quest Diagnostics — see the exact pricing on our Lab Pricing page. If you have insurance, let us know — we can often order your labs under your coverage instead. Every protocol needs at least our Base Panel. If you've had labs done within the last 12 months, attach the PDF on the request form, or authorize us to pull your results directly if they were drawn at Quest or LabCorp.
Often, yes. If you have insurance, mention it on the request form and we can order your labs under your coverage instead of the at-cost Quest price. Coverage depends on your specific plan and which labs your protocol requires, so our team will confirm what applies to you before anything is ordered. Peptide and compounded-medication protocols themselves are typically self-pay, but the labs behind them are often billable to insurance.
Your request is placed on hold rather than automatically denied. A provider will reach out to explain what was out of range and what your options are — that might mean addressing the underlying issue first, adjusting the protocol, or in some cases determining the protocol isn't a fit right now.
Most protocols are set to a 90-day retest cadence. Some, particularly growth-hormone-related protocols monitored via IGF-1, may be checked sooner. Our team will reach out by phone or text when a retest is coming up.
Most of the research peptides in our library (BPC-157, TB-500, CJC-1295, Ipamorelin) are not FDA-approved for the uses discussed here. PT-141 has an FDA-approved form for a specific indication; whether another formulation fits your protocol is a provider's clinical decision. Compounded medications, including personalized GLP-1 formulations, are not themselves FDA-approved products, and their availability depends on current pharmacy regulations, which we monitor closely.
The biggest difference is the medical team behind it. Every request goes through a reviewed lab panel and a licensed provider's sign-off, and we keep retesting on your calendar rather than leaving it up to you to remember. Compounded medications also include a telehealth visit, so a real provider is looking at your specific labs and history — not just processing an order.
Reach out through the contact page and let us know what you're looking for. If it's something our medical team supports, we'll route you to the right intake and lab requirements.
In many cases, yes — just note it on the request form and we'll pick up where your protocol left off. Availability can depend on state-specific telehealth and pharmacy rules, so our team will confirm what's possible for your new location before anything is approved.
